21 May 2026
CTO PCI: an evolving landscape
Session comprising selected EuroPCR 2026 abstract submissions
Moderators:
A. Elguindy, J. Davies
Summary
Review the evolving landscape of chronic total occlusion (CTO) PCI with a focus on recent trends, contemporary management in multivessel disease, and innovative techniques such as retrograde approaches and titrated contrast recanalization. This session also addresses cost-effectiveness and drug-coated balloon (DCB) therapy outcomes from multicenter studies.